STOCK TITAN

Zai Lab: RTW reports 9.2% passive ownership stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Zai Lab Ltd. reporting persons RTW Investments, LP and Roderick Wong, M.D., reported shared voting and dispositive power over 103,509,730 ordinary shares, representing 9.2% of the class. The shares are directly held by the RTW Funds, which have the right to receive or direct dividends and sale proceeds. The percentage is based on 1,122,662,280 ordinary shares outstanding as of July 31, 2026.

Ordinary shares beneficially owned 103,509,730 shares Reported by each reporting person as shared voting and dispositive power; directly held by the RTW Funds.
Ownership percentage 9.2% Reported for each reporting person, based on 1,122,662,280 ordinary shares outstanding as of July 31, 2026.
Ordinary shares outstanding 1,122,662,280 shares As of July 31, 2026.
ADS ratio 10 ordinary shares per ADS Each American Depositary Share represents ten ordinary shares.
Shared Voting Power financial
"Shared Voting Power 103,509,730 Shares"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Power financial
"Shared Dispositive Power 103,509,730 Shares"
American Depositary Shares technical
"CUSIP number 98887Q104 has been assigned to the American Depositary Shares"
American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.
beneficial owner regulatory
"should not be construed as an admission ... beneficial owner of the Shares"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ZLAB shares did RTW Investments and Roderick Wong report?

They each reported shared voting and dispositive power over 103,509,730 ordinary shares, equal to 9.2% of the class. Both reports concern shares directly held by the RTW Funds.

How many Zai Lab ordinary shares does one ADS represent?

Each American Depositary Share represents 10 ordinary shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





98887Q104

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



RTW Investments, LP
Signature:/s/ Roderick Wong, M.D.
Name/Title:By Roderick Wong, M.D., Managing Partner
Date:11/16/2026
Roderick Wong
Signature:/s/ Roderick Wong, M.D.
Name/Title:Roderick Wong, M.D.
Date:11/16/2026
Exhibit Information

Exhibit 99.1 Joint Filing Agreement (incorporated by reference to Exhibit 99.1 to the Reporting Persons' Schedule 13G filed with the SEC on February 17, 2026).

Keep reading